About Proteocyte Diagnostics Proteocyte Diagnostics Inc. is a Canadian molecular diagnostics company that develops and commercializes
a novel diagnostics technology, Straticyte ™ that offers objective and accurate early diagnosis of precancers and cancers.
Not exact matches
In 1996, Alexandria founded Alexandria Venture Investments to actively invest at the cutting edge of
novel, breakthrough discoveries in biopharmaceuticals,
diagnostics, research tools, medical devices, digital health, and
technology.
Ativa Medical Corp. is a privately held, emerging growth medical
diagnostic company developing and commercializing
novel point - of - care
diagnostic technologies.This
technology will enable health care professionals to perform critical hematology and blood chemistry tests on - site and get accurate results within about 5 minutes.
«We believe that HLI's unique science and
technology, along with our business leadership, will positively impact the healthcare market with
novel diagnostics and therapeutics.»
Both of her clinical labs focus on the rapid translation of new genetic discoveries into clinical tests and bringing
novel technologies and software systems into molecular
diagnostics to support the integration of genetics into clinical use.
The Pathology Shared Resource facilitates project planning, clinical validation and implementation of
novel translational
technology and research in the fields of molecular
diagnostics, molecular therapeutics, pharmacogenomics, quantitative morphologic image analysis and immunohistochemistry (IHC) in a CLIA - certified, CAP - accredited laboratory ensuring optimal clinical quality assurance.